InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-31.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by WAGENHEIM PHILIP, Director. Director active across 1 company, notably Immunome Inc.. Aggregated, 3 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €406k. History available since 24 May 2021. The latest transaction was filed on 15 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
8,750 shares@ US$4.007.4% of flowCommon StockSEC:0001104659-23-004010:0
13,500 shares@ US$18.3550.0% of flowCommon StockSEC:0001104659-21-072619
Ideal exit: 18 Feb 2022 (T+270)
13,500 shares@ US$18.350.0086% mcap50.0% of flowCommon StockSEC:0001104659-21-072619:0
Ideal exit: 18 Feb 2022 (T+270)
3 of 3 declarations
About WAGENHEIM PHILIP
Philip Wagenheim is a Director at Immunome Inc. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for Immunome.
